Related Experiment Video
Updated: Nov 30, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
The Mystery of MIS-C Post-SARS-CoV-2 Infection
Nina N Brodsky1, Anjali Ramaswamy2, Carrie L Lucas2
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Insights
The coronavirus disease 2019 (COVID-19) pandemic has seen a rise in multisystem inflammatory syndrome in children (MIS-C). New studies investigate the immune responses driving this severe condition in pediatric patients infected with SARS-CoV-2.
Area of Science:
- Pediatric immunology
- Infectious diseases
- Viral pathogenesis
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 has led to a rise in MIS-C, a serious condition in children.
- MIS-C presents unique challenges in understanding SARS-CoV-2's impact on pediatric populations.
Purpose of the Study:
- To investigate the immune system's role in the development of MIS-C.
- To elucidate the specific immune mechanisms triggered by SARS-CoV-2 infection in children and adolescents.
Main Methods:
- Analysis of immune cell populations and cytokine profiles in MIS-C patients.
- Comparative studies examining immune responses in children with and without MIS-C.
Main Results:
- Identification of distinct immune signatures associated with MIS-C.
- Evidence suggesting specific T-cell and cytokine dysregulation in pediatric MIS-C.
Conclusions:
- The findings shed light on the complex immune pathways implicated in MIS-C.
- Further research into these immune drivers may lead to targeted therapies for MIS-C.
Abstract:
Following emergence of the coronavirus disease 2019 (COVID-19) pandemic, a surge in the life-threatening illness now termed 'multisystem inflammatory syndrome in children' (MIS-C) has raised questions about the unique effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents. Two important new studies by Consiglio et al. and Gruber et al. have begun to shine light on the immune drivers of this enigmatic disease.
Related Concept Videos
Viral Recombination
Single Nucleotide Polymorphisms-SNPs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Steps in Outbreak Investigation

